Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$76,898.00-2.21%ETH$2,236.92-1.07%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
Elevance Health Inc. logo

NYSE · ELV

Elevance Health Inc.

Healthcare · Medical - Healthcare Plans

$422.02

Down-$1.95 (-0.46%)

Updated Oct 30, 2026, 11:03 PM

SID Score

7.8/10

Composite research score

Smart Money

54/100

Neutral

Market cap
80.05B
P/E ratio
14.7
Dividend yield
1.62%
52-week range
$274.84 – $450.69
Volume
1.04M
Avg. volume
1.72M

Price performance · ELV

ELV price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

ELV closed at $422.02 after 21 trading sessions, up 10.57% for the selected period.

Last close
$422.02
Period change
+10.57%
Period low
$381.67
Period high
$445.28
Daily close
View OHLC price history
ELV OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$419.00$422.555$417.51$422.021.04M
Oct 28, 2026$419.68$424.58$411.31$414.411.19M
Oct 27, 2026$429.96$434.38$418.66$421.491.54M
Oct 26, 2026$441.30$442.245$429.84$431.321.44M
Oct 23, 2026$442.27$445.42$439.00$439.951.17M
Oct 22, 2026$432.56$449.95$431.20$445.281.43M
Oct 21, 2026$445.00$450.69$426.13$434.132.47M
Oct 20, 2026$432.87$440.67$431.09$440.181.55M
Oct 19, 2026$427.19$435.50$425.00$430.23998.33K
Oct 16, 2026$433.34$434.00$426.72$428.261.22M
Oct 15, 2026$429.00$432.255$424.87$428.431.52M
Oct 14, 2026$428.82$434.00$421.78$428.092.12M
Oct 13, 2026$427.00$433.89$420.99$425.271.84M
Oct 12, 2026$415.00$423.98$413.695$422.09869.49K
Oct 9, 2026$401.92$418.5599$400.94$412.702.08M
Oct 8, 2026$403.83$407.37$397.1236$400.94786.33K
Oct 7, 2026$401.00$410.54$399.98$404.31904.79K
Oct 6, 2026$396.68$400.97$394.4226$400.091.23M
Oct 5, 2026$387.67$395.9925$385.00$394.51712.11K
Oct 2, 2026$382.09$388.04$380.65$386.43892.68K
Oct 1, 2026$388.00$390.37$375.74$381.671.19M

Latest ELV news

The latest Smart Investors Daily articles mentioning ELV.

Stock researchCompany · Overview

ELV research

Overview

Company profile and research snapshot.

Company profile

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$389.63
Implied upside
—
Analysts
19
ELV recent ratings
DateFirmRatingTarget
Oct 27, 2026Wells FargoOverweight—
Oct 23, 2026TD CowenBuy—
Oct 22, 2026BarclaysOverweight—
Oct 22, 2026RBC CapitalSector Perform—
Oct 22, 2026Morgan StanleyEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 27, 2026

Evaluating Elevance Health (ELV) After Prolonged Share Price Weakness And 17.3% Undervaluation Estimate

With no single headline event driving attention, Elevance Health (ELV) has drawn investor interest after a mixed share price record, including a 16.18% decline over the past year and a 27.89% decline over three years. See our latest analysis for Elevance Health. Recent trading has been soft, with a 7 day share price return of 7.22% and a year to date share price return decline of 8.81%, while the 1 year total shareholder return decline of 16.18% and 3 year total shareholder return decline of...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By